How meth, cocaine, and 'bath salts' can drive rapid, compulsive use
Dissecting the Abuse Liability of Cathinone and Amphetamine Stimulants
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN DIEGO · NIH-11167876
This work looks at what situations and drug types make stimulant use escalate into bingeing and dependence, with relevance for adults who use meth, cocaine, or synthetic cathinones.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN DIEGO (nih funded) |
| Locations | 1 site (LA JOLLA, UNITED STATES) |
| Trial ID | NIH-11167876 on ClinicalTrials.gov |
What this research studies
If you or someone you know struggles with stimulant use, researchers are using rat models that self-administer drugs to mimic binge-like and escalating patterns seen in people. They compare classic stimulants (methamphetamine, cocaine) with synthetic cathinones (so-called 'bath salts') to see which drugs and situations most strongly promote rapid escalation. The team measures behavior and brain changes to pinpoint mechanisms that lead to compulsive use. Findings aim to reveal patterns or targets that could inform prevention or future treatments for stimulant addiction.
Who could benefit from this research
Good fit: Adults (21+) who use or have a history of using stimulants such as methamphetamine, cocaine, or synthetic cathinones, or those at high risk for stimulant dependence, would be the most relevant group.
Not a fit: People who do not use stimulants, are under age 21, or are seeking help for non-stimulant conditions are unlikely to receive direct benefit from this work.
Why it matters
Potential benefit: Could reveal high-risk use patterns and brain targets that lead to new prevention approaches or therapies for stimulant addiction.
How similar studies have performed: Animal studies consistently show cathinones and amphetamines are highly reinforcing, but prior attempts to produce vaccines or small-molecule treatments for stimulant dependence have not yet yielded approved therapies.
Where this research is happening
LA JOLLA, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN DIEGO — LA JOLLA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TAFFE, MICHAEL A. — UNIVERSITY OF CALIFORNIA, SAN DIEGO
- Study coordinator: TAFFE, MICHAEL A.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.